U.S. flag

An official website of the United States government

NM_153682.3(PIGP):c.384del (p.Glu129fs) AND Developmental and epileptic encephalopathy, 55

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Aug 10, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000496365.17

Allele description [Variation Report for NM_153682.3(PIGP):c.384del (p.Glu129fs)]

NM_153682.3(PIGP):c.384del (p.Glu129fs)

Gene:
PIGP:phosphatidylinositol glycan anchor biosynthesis class P [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
21q22.13
Genomic location:
Preferred name:
NM_153682.3(PIGP):c.384del (p.Glu129fs)
HGVS:
  • NC_000021.9:g.37065605del
  • NM_001320480.2:c.384del
  • NM_016430.4:c.306del
  • NM_153681.2:c.456del
  • NM_153682.3:c.384delMANE SELECT
  • NP_001307409.1:p.Glu129fs
  • NP_057514.2:p.Glu103fs
  • NP_710148.1:p.Glu153fs
  • NP_710149.1:p.Glu129fs
  • NP_710149.1:p.Glu129fs
  • NC_000021.8:g.38437903del
  • NC_000021.8:g.38437905del
  • NM_153681.2:c.456delA
  • NM_153682.2:c.384del
  • NM_153682.2:c.384del
Protein change:
E103fs
Links:
OMIM: 605938.0002; dbSNP: rs778481061
NCBI 1000 Genomes Browser:
rs778481061
Molecular consequence:
  • NM_001320480.2:c.384del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_016430.4:c.306del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_153681.2:c.456del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_153682.3:c.384del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
2

Condition(s)

Name:
Developmental and epileptic encephalopathy, 55
Synonyms:
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 14; Early infantile epileptic encephalopathy 55
Identifiers:
MONDO: MONDO:0033364; MedGen: C4539843; OMIM: 617599

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000586814OMIM
no assertion criteria provided
Pathogenic
(Nov 11, 2020)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

SCV001150211Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
criteria provided, single submitter

(Classification criteria August 2017)
Pathogenic
(Oct 11, 2018)
germlineclinical testing

Citation Link,

SCV002024631Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 29, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002567983DASA
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 10, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes2not providednot provided1not providedclinical testing

Citations

PubMed

Early infantile epileptic-dyskinetic encephalopathy due to biallelic PIGP mutations.

Vetro A, Pisano T, Chiaro S, Procopio E, Guerra A, Parrini E, Mei D, Virdò S, Mangone G, Azzari C, Guerrini R.

Neurol Genet. 2020 Feb;6(1):e387. doi: 10.1212/NXG.0000000000000387.

PubMed [citation]
PMID:
32042915
PMCID:
PMC6984131

Biallelic mutations in PIGP cause developmental and epileptic encephalopathy.

Krenn M, Knaus A, Westphal DS, Wortmann SB, Polster T, Woermann FG, Karenfort M, Mayatepek E, Meitinger T, Wagner M, Distelmaier F.

Ann Clin Transl Neurol. 2019 May;6(5):968-973. doi: 10.1002/acn3.768.

PubMed [citation]
PMID:
31139695
PMCID:
PMC6530525
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000586814.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

For discussion of the 1-bp deletion (c.456delA, NM_153681.2) in the PIGP gene, resulting in a frameshift and premature termination (Glu153AsnfsTer34), that was found in compound heterozygous state in 2 sibs with developmental and epileptic encephalopathy-55 (DEE55; 617599) by Johnstone et al. (2017), see 605938.0001.

In a 2-year-old girl, born of unrelated Polish parents, with DEE55, Krenn et al. (2019) identified homozygosity for the c.456delA mutation in the PIGP gene. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. It was found at low frequencies in only heterozygous state in an in-house database (6 in over 16,000 exomes) and gnomAD (9 exomes). Flow cytometric analysis of patient lymphocytes showed decreased expression of GPI-anchored proteins, suggesting a loss-of-function effect. The findings confirmed PIGP as a monogenic disease causing developmental and epileptic encephalopathy. The patient had onset of refractory focal seizures at 7 months of age. Developmental milestones were not reached.

In 4 affected individuals from a large consanguineous kindred with DEE55, Vetro et al. (2020) identified a homozygous 1-bp deletion (c.384del, NM_153682.2) in the PIGP gene, predicted to result in a frameshift and premature termination (Glu129AsnfsTer34). The authors stated that this was the same mutation as that reported by Krenn et al. (2019). The mutation identified by Vetro et al. (2020) was found by exome sequencing and confirmed by Sanger sequencing. It segregated with the disorder in the family and was found at a low frequency in the gnomAD database (3 x 10(-5)). Flow cytometric analysis of patient lymphocytes showed decreased levels of the GPI-anchored protein CD16 (146740) and mildly decreased levels of CD24 (600074), whereas expression of another GPI-anchored protein, CD55 (125240), was normal. The patients had onset of refractory focal and generalized seizures at 3 months of age. EEG showed burst-suppression pattern. The patients achieved almost no developmental milestones; 2 died at 12 years and 27 months, respectively.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München, SCV001150211.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1bloodnot provided1not providednot providednot provided

From Revvity Omics, Revvity, SCV002024631.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From DASA, SCV002567983.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

The c.384del;p.(Glu129Asnfs*34) is a null frameshift variant (NMD) in the PIGP gene without sufficient information about prediction of nonsense mediated mRNA decay (NMD); it is present in a relevant exon to the transcript, and disrupts < 10% of the protein product – PVS1_moderate. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant(ClinVar ID: ID: 397552; OMIM: 605938.0002; PMID: 32042915; 31139695; 28334793) - PS4. The variant is present at low allele frequencies population databases (rs778481061 – gnomAD 0.0003944%; ABraOM no frequency - https://abraom.ib.usp.br/) -PM2_supporting.The p.(Glu129Asnfs*34) was detected in trans with a pathogenic variant (PMID: 32042915; 31139695; 28334793) - PM3_strong. The variant co-segregated with disease in multiple affected family members (PMID: 32042915) - PP1_moderate. In summary, the currently available evidence indicates that the variant is pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 20, 2024